AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $140.21
- 52-wk high
- $147.21
- High
- $141.27
- 52-wk low
- $91.72
- Low
- $137.37
- Prev close
- $138.50
- Mkt cap
- $232.32B
- P/E
- 14.9x
- Volume
- 7.39M
- Fwd P/E
- 10.6x
- Beta
- 1.10
- Div yield
- 1.74%
- P/S
- 2.8x
- P/B
- 1.2x
- Profit margin
- +21.8%
- Op margin
- +36.2%
- ROE
- +8.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 15.8% above what analysts expected.
Earnings per share
$2.72 expected
Reports Oct 13, 2026, in 30 days
EPS expected
$2.39 to $2.73
Revenue expected
15 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $43.84B | $40.65B | $44.44B | $45.30B |
| Cost of what it sold | $24.19B | $23.16B | $22.59B | $23.04B |
| Gross profit | $19.66B | $17.49B | $21.84B | $22.26B |
| What it spent | ||||
| Research and development | $2.33B | — | — | — |
| Sales and admin | $7.49B | $7.09B | $8.39B | $8.01B |
| Other operating costs | $4.49B | $6.59B | $5.93B | $6.22B |
| Total operating expenses | $14.31B | $13.68B | $14.32B | $14.23B |
| What was left | ||||
| Operating profit | $5.35B | $3.81B | $7.52B | $8.03B |
| Interest on debt | $21.75B | $20.98B | $19.77B | $20.54B |
| Profit before tax | $5.35B | $3.81B | $7.52B | $8.03B |
| Tax | $1.56B | $1.29B | $1.58B | $2.00B |
| Net profit | $3.75B | $2.47B | $5.79B | $5.83B |
| EBITDA | $6.47B | $4.91B | $8.63B | $9.18B |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
EXCLUSIVE: Silver Lake, Intel-backed Altera prepares IPO that could raise over $2 billion as early as 2026, sources say
Leans bullishSep 11Olema Oncology at citigroup summit: palazestrant data, delays
NeutralSep 10Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push
NeutralSep 10Transcript : Novavax, Inc. Presents at Citigroup’s Biopharma Back to School Summit 2026, Sep-10-2026 10
NeutralSep 10Wells Fargo expands neurodiversity hiring program as banking industry pulls back on DEI
NeutralSep 10SpyGlass Pharma at Citigroup summit: glaucoma lens nears phase iii By Investing.com
NeutralSep 10SAB BIO at Citi summit: trial progress and a bigger t1d bet
NeutralSep 10Stifel Nicolaus Begins Coverage on Matador Resources (NYSE:MTDR)
NeutralSep 10